Multicenter Study of Fulminant Type 1 Diabetes in China

This study took FT1D（fulminant type 1 diabetes） as the research object, collected the cases of FT1D patients, and described the clinical characteristics of this type of disease. The HLA susceptibility genes of FT1D were identified by PCR and other techniques, taking age-sex-matched healthy subjects as controls and HLA genes as the research entry point.

NCT Number	NCT05593081
Lead Sponsor	Second Xiangya Hospital of Central South University
Conditions	Diabetes Mellitus, Type 1
Enrollment	240 participants
Start Date	2022-05-20
Primary Completion	2027-12-31 (estimated)
Study Completion	2027-12-31 (estimated)
Updated on ClinicalTrials.gov	2022-10-25